Probetex公司是一家成立于1997年的生命科学与合同研究机构（CRO），公司列举了6个专业领域，包括：1）成*人和胚胎肾细胞系的细胞库; 2）产生和销售绵羊肾毒性抗体以诱导抗肾小球基底膜（抗GBM）肾小球肾炎，膜性（抗-Fx1A）肾病和系膜增殖性（抗-Thy1）肾小球肾炎。3）来自肾病模型的组织产品; 4）提供常规组织学，免疫组织化学，电子显微镜和图像分析的组织病理学服务; 5）专门从事上述模型的定制合同研究，以及其他20多种急，慢性实验性肾病，心血管肝，肺疾病模型; Probetex还协助评估和开发罕见疾病模型。

Probetex提供广泛的组织病理学产品，包括肾毒性抗体以诱导肾小球疾病的三种经典模型，成*人和胚胎肾祖细胞，源自免疫介导的肾脏疾病的组织产品和BioScout *免疫荧光参考抗体以帮助结构定位在黑暗的背景中的抗原。

肾毒性抗体（抗GBM，抗Fx1A，抗Thy-1）
组织产品
细胞（成*人和胚胎肾）

BioScout *参考抗体

实验病理资源
学术和商业方法的生命科学和疾病研究

肾毒性抗血清

组织病理学

疾病模型
[R

细胞和细胞培养

再生医学

客户支持

血管炎研究计划
Probetex, Inc. is a life science and contract research organization (CRO) founded in 1997, The company lists six specialization areas including 1) A cell bank of a/dult and embryonic kidney cell lines; 2) Production and sale of sheep nephrotoxic antibodies to induce anti-glomerular basement membrane (anti-GBM) glomerulonephritis, membranous (anti-Fx1A) nephropathy, and mesangioproliferative (anti-Thy1) glomerulonephritis. 3) Tissue products from renal disease models; 4) Histopathology services providing routine histology, immunohistochemistry, electron microscopy and image analysis; 5) Custom contract research specializing in the above models as well as over 20 other models of acute and chronic experimental kidney disease, cardiovascular liver and lung disease; and 6) other specialty areas such as regenerative medicine and a new initiative to raise funds for the development of new models of anti-neutrophil cytoplasmic antibody(ANCA) vasculitis. Probetex also assists in the assessment and development of rare disease models.